I et 3- års substudie under PEARL- studiet (n=760) forøgede Fablyn signifikant BMD (sammenlignet med placebo) i lænderygsøjle (3, 3%), total hofte (3, 0%), lårbenshals (3, 3%), trochanter major (3, 6%), intertrochantær- område (2, 6%), Wards trekant (5, 9%) og underarm (1, 8%) efter 3 år.
In a 3-year substudy of the PEARL study (n=760), FABLYN significantly increased BMD (compared to placebo) at lumbar spine (3.3%), total hip (3.0%), femoral neck (3.3%), greater trochanter (3.6%), intertrochanteric area (2.6%), Ward’ s triangle (5.9%) and forearm (1.8%) at 3 years.